FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a dramatic ...
The Independent Data Monitoring Committee recommended transitioning patients in the placebo arm to garetosmab as soon as possible. Topline data were announced from a phase 3 trial evaluating ...
In a study published in the journal Genes & Diseases, researchers from Army Medical University and Shenzhen University investigated the pivotal role of miR-18a-5p, a microRNA, in the development and ...
A new study led by Yale School of Medicine's Department of Orthopedics & Rehabilitation unveiled key insights into the knee ...
ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently in Phase 2a clinical trials for treatment of metastatic breast ...
The 3 mg/kg dose achieved a 94% reduction in new bone lesions, while the 10 mg/kg dose showed a 90% reduction. Based on the positive data and safety profile, the Independent Data Monitoring Committee ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback